• 1
    Almarri A, Batchelor JR. HLA and hepatitis B infection [see comments]. Lancet 1994;344: 11945.
  • 2
    Lu SJ, Day NE, Degos L, Lepage V, Wang PC, Chan SH, Simons M, McKnight B, Easton D, Zeng Y, et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990;346: 4701.
  • 3
    Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia [see comments]. N Engl J Med 1995;332: 10659.
  • 4
    Oza AM, Tonks S, Lim J, Fleetwood MA, Lister TA, Bodmer JG. A clinical and epidemiological study of human leukocyte antigen-DPB alleles in Hodgkin's disease. Cancer Res 1994;54: 51015.
  • 5
    Burt RD, Vaughan TL, Nisperos B, Swanson M, Berwick M. A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians. Int J Cancer 1994;56: 4657.
  • 6
    Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999;341: 16338.
  • 7
    zur Hausen H. Papillomavirus infections: a major cause of human cancers. Biochim Biophys Acta 1996;1288: F5578.
  • 8
    Schiffman MH, Brinton LA. The epidemiology of cervical carcinogenesis. Cancer 1995;76: 1888901.
  • 9
    Lowy DR, Kirnbauer R, Schiller JT. Genital human papillomavirus infection. Proc Natl Acad Sci USA 1994;91: 243640.
  • 10
    Ahlbom A, Lichtenstein P, Malmstrom H, Feychting M, Hemminki K, Pedersen NL. Cancer in twins: genetic and nongenetic familial risk factors. J Natl Cancer Inst 1997;89: 28793.
  • 11
    Magnusson PK, Sparen P, Gyllensten UB. Genetic link to cervical tumours [letter]. Nature 1999;400: 2930.
  • 12
    Odunsi K, Terry G, Ho L, Bell J, Cuzick J, Ganesan TS. Association between HLA DQB1 * 03 and cervical intra-epithelial neoplasia. Mol Med 1995;1: 16171.
  • 13
    Apple RJ, Becker TM, Wheeler CM, Erlich HA. Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma. J Natl Cancer Inst 1995;87: 42736.
  • 14
    Wank R, Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA- DQw3 [see comments]. Nature 1991;352: 7235.
  • 15
    Glew SS, Duggan-Keen M, Ghosh AK, Ivinson A, Sinnott P, Davidson J, Dyer PA, Stern PL. Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer. Hum Immunol 1993;37: 15764.
  • 16
    Helland A, Olsen AO, Gjoen K, Akselsen HE, Sauer T, Magnus P, Borresen-Dale AL, Ronningen KS. An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102- DQB1*0602 haplotype: a population-based case-control study of Norwegian women. Int J Cancer 1998;76: 1924.
  • 17
    Sanjeevi CB, Hjelmstrom P, Hallmans G, Wiklund F, Lenner P, Angstrom T, Dillner J, Lernmark A. Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women. Int J Cancer 1996;68: 40914.
  • 18
    Chua KL, Hjerpe A. Polymerase chain reaction analysis of human papillomavirus in archival cervical cytologic smears. Anal Quant Cytol Histol 1995;17: 2219.
  • 19
    Chua KL, Hjerpe A. 1996. Persistence of human papillomavirus (HPV) infections preceding cervical carcinoma. Cancer 1996;77: 1217.
  • 20
    Rhoads DD, Dixit A, Roufa DJ. Primary structure of human ribosomal protein S14 and the gene that encodes it. Mol Cell Biol 1986;6: 277483.
  • 21
    Erlich HA, Bugawan BL. HLA class II gene polymorphisms: DNA typing, evolution and relationship to disease susceptibility. In: ErlichHA, ed. PCR technology: principles and applications for DNA amplification. New York: Stocktorn Press, 1989. 193208.
  • 22
    Sanjeevi CB, Seshiah V, Moller E, Olerup O. Different genetic backgrounds for malnutrition-related diabetes and type 1 (insulin-dependent) diabetes mellitus in south Indians. Diabetologia 1992;35: 2836.
  • 23
    Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. Use of polymerase chain reaction for detection of genital human papillomaviruses. In: FurthM, GreavesM, eds. Molecular diagnostics of human cancer. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989. vol. 7, 20914.
  • 24
    de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76: 105762.
  • 25
    Evander M, Edlund K, Boden E, Gustafsson A, Jonsson M, Karlsson R, Rylander E, Wadell G. Comparison of a one-step and a two-step polymerase chain reaction with degenerate general primers in a population-based study of human papillomavirus infection in young Swedish women. J Clin Microbiol 1992;30: 98792.
  • 26
    Chua KL, Wiklund F, Lenner P, Angstrom T, Hallmans G, Bergman F, Sapp M, Schiller J, Wadell G, Hjerpe A, Dillner J. 1996. A prospective study on the risk of cervical intra-epithelial neoplasia among healthy subjects with serum antibodies to HPV compared with HPV DNA in cervical smears. Int J Cancer 1996;68: 549.
  • 27
    Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol 1976;103: 22635.
  • 28
    Woolf B. On estimating the relation between blood group and disease. Am Hum Genet 1955: 251253.
  • 29
    Maciag PC, Schlecht NF, Souza PS, Franco EL, Villa LL, Petzl-Erler ML. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiol Biomarkers Prev 2000;9: 118391.
  • 30
    Bontkes HJ, van Duin M, de Gruijl TD, Duggan-Keen MF, Walboomers JM, Stukart MJ, Verheijen RH, Helmerhorst TJ, Meijer CJ, Scheper RJ, Stevens FR, Dyer PA, et al. 1998. HPV 16 infection and progression of cervical intra-epithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int J Cancer 1998;78: 16671.
  • 31
    Campbell RD, Trowsdale J. Map of the human MHC. Immunol Today 1993;14: 34952.
  • 32
    Trowsdale J, Powis SH. The MHC: relationship between linkage and function. Curr Opin Genet Dev 1992;2: 4927.
  • 33
    Glew SS, Connor ME, Snijders PJ, Stanbridge CM, Buckley CH, Walboomers JM, Meijer CJ, Stern PL. HLA expression in pre-invasive cervical neoplasia in relation to human papilloma virus infection. Eur J Cancer 1993;14: 196370.
  • 34
    Farthing AJ, Vousden KH. Functions of human papillomavirus E6 and E7 oncoproteins. Trends Microbiol 1994;2: 1704.
  • 35
    Zhu K, Wang J, Zhu J, Jiang J, Shou J, Chen X. p53 induces TAP1 and enhances the transport of MHC class I peptides. Oncogene 1999;18: 77407.
  • 36
    Keating PJ, Cromme FV, Duggan-Keen M, Snijders PJ, Walboomers JM, Hunter RD, Dyer PA, Stern PL. Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. Br J Cancer 1995;72: 40511.
  • 37
    Meneguzzi G, Cerni C, Kieny MP, Lathe R. Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7. Virology 1991;181: 629.